Celia Diez de los Rios, Lecturer at the University of Navarra, Spain, Board Member at From Testing to Targeted Treatments (FT3), Oncology Advanced Nurse Practitioner, Research Fellow at the University of Glasgow, shared a post on LinkedIn:
“As the Good Day Project reaches its final steps, I find myself thinking less about results and more about people who made it meaningful.
This project was never only about research questions or outcomes. It was about listening.
- Listening to patients describing what a ‘good day’ truly means while living with cancer.
- Listening to organisations advocating for visibility.
- Listening to experiences that do not always appear in clinical endpoints but shape everyday life.
What stayed with me most is how often good days were defined not by absence of illness, but by presence of normality, nature, connection, autonomy…
I am deeply grateful to every patient, advocate, and organisation who trusted us with their stories and perspectives. Your voices will continue to shape how we think about care, survivorship, and what outcomes really matter.
I hope we will soon share this work more widely at upcoming conferences and conversations continuing what has always been the project’s purpose: bringing patient experience closer to decision-making.
Because sometimes the most meaningful innovation in healthcare begins by asking a simple question: ‘What makes today a good day?’
Thank you Grigorios Kotronoulas for being you and teaching me everyday and for dreaming with me on a different outcome for many. Thank you Wendy Oldenmenger, Amanda Drury, Daniel Kelly OBE for being part of this and also share your knowledge and European Oncology Nursing Society (EONS)
Thank you to each of the organisations that have been part of this and for each person who listened to this and smiled Merel Hennink, Renée Dubois, Kathy Oliver and many others.”
Other Articles Featuring Celia Diez de los Rios on OncoDaily.